NOVEL TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150119395A1
SERIAL NO

14390737

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel triazole Hsp90 inhibitors that possess significant inhibitory activity against Hsp90, which are suitable for the treatment of hyperproliferative diseases such as cancer, infections, immune disorders, inflammation, and CNS related disorders. Furthermore, pharmaceutical compositions, including combination products, are also provided in the present application. Further provided are methods of using the pharmaceutical compositions and/or combination products.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTA PHARMACEUTICALS CORP45 HARTWELL AVENUE LEXINGTON MA 02421

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chimmanamada, Dinesh U Arlington, US 52 975
Ying, Weiwen Lexington, US 100 1571

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation